Tuesday, October 03, 2017 8:34:42 PM
My connection was dead-on with the time frame of news hitting and when your last days to get in cheap were (posted on 9/14 that we had 2-4 weeks and maybe less but that I would get in that week or the next). Glad I listened to myself and bought more.....and so far the info I got looks to be exactly right and the trial news about as good as it gets.
I really think we will be over a dollar in 6 months or less, obviously dependent on the speed that ENDV and the FDA get things done.
The great news, as most of us assume already, is that once we are successful with heart...the rest of the trials will fall right in line. The first one was and is the most crucial and for it to be passing with such good news is a humongous sign of what's to come.
As we have all seen, sometimes time frames and dates don't always happen as expected, especially in this sector. I mean....its October and we still are waiting for the data and official word to come down from the end of March. So that's 6 months later than the first initial guess they put out last year.
But here we are.....finally!
No new news to report on my end. Its all still coming to fruition from my last update. Everything looks great from what I hear. Word is that it has gone perfectly and news will be "very positive!"
Feels good to see the numbers in your brokerage accounts finally look normal.
I'll update whenever anything new that I can share comes up. Until then, just laying low and enjoying it.
BTW- a few have messaged me privately. I no longer pay here so my pm's are gone.
Recent ENDV News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/02/2024 10:23:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:30:14 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 12/29/2023 08:20:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:08:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 05:21:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 10:03:32 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 08/25/2023 11:04:33 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:16:04 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM